Clinical Trial Update: Protective Role of Oxcarbazepine in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the protective role of oxcarbazepine in multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Queen Mary University of London | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED